Physician profile
Antonio C Cano
NPI 1174525778
$6,585.31
in general payments reported to CMS, 2019-2025
21 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,687 · 2020: $1,470 · 2021: $1,114 · 2022: $1,020 · 2023: $556 · 2024: $346 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.23 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,421.09 | 2019-2025 | Aveir, Perclose Prostyle, Confirm Rx |
| Janssen Pharmaceuticals, INC | $848.61 | 2019-2022 | |
| Medtronic, INC. | $840.72 | 2022-2025 | Onyx Frontier, Claria Mri Quad Crt-D Surescan, Hawkone |
| Medtronic Vascular, INC. | $395.37 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.39 | 2019-2023 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $324.41 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $275.06 | 2019-2025 | Camzyos |
| Atricure, INC. | $137.76 | 2022 | |
| Amgen INC. | $130.50 | 2019-2023 | Repatha |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $129.30 | 2019 | |
| Boston Scientific Corporation | $119.36 | 2019-2023 | Watchman Access System |
| Osprey Medical INC | $113.56 | 2021 | |
| Surmodics, INC. | $101.81 | 2022-2023 | Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Pfizer INC. | $92.64 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $84.18 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $73.67 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $61.92 | 2021 | |
| Asahi Intecc USA, INC. | $37.59 | 2024 | Peripheral Vascular |
| Abiomed | $23.60 | 2025 | |
| Impulse Dynamics (USA) INC. | $22.02 | 2022 | |
| Acist Medical Systems, INC. | $16.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Cano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.